(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Abroad (travel likely)RecruitingPHASE2

Conditions

Advanced Systemic Mastocytosis (AdvSM) · SM With an Associated Hematologic Neoplasm (SM-AHN) · Mast Cell Leukemia (MCL) · Aggressive Systemic Mastocytosis (ASM)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Alabama at Birmingham (UAB) Hospital, Birmingham, Alabama, United States

  • Mayo Clinic Arizona, Phoenix, Arizona, United States

  • City of Hope Comprehensive Cancer Center, Duarte, California, United States

  • UCLA Medical Center, Los Angeles, California, United States

  • Stanford Cancer Institute, Stanford, California, United States

  • Galiz Research, Hialeah, Florida, United States

  • Winship Cancer Institute - Emory University, Atlanta, Georgia, United States

  • Rush University Medical Center, Chicago, Illinois, United States

  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

  • Columbia University Irving Medical Center, New York, New York, United States

  • Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States

  • MUSC Health University Medical Center, Charleston, South Carolina, United States

  • The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • Huntsman Cancer Institute - University of Utah Health, Salt Lake City, Utah, United States

  • Nepean Hospital, Kingswood, New South Wales, Australia

  • Gold Coast University Hospital, Southport, Queensland, Australia

  • Peter MacCallum Cancer Centre, Melbourne N., Victoria, Australia

  • AKH Wien, Universitatsklinikum, Vienna, Austria

  • CHU de Liege, Liège, Belgium

  • University of Alberta Hospital, Edmonton, Alberta, Canada

  • St. Michael's Hospital - Unity Health Toronto, Toronto, Ontario, Canada

  • Necker-Enfants Malades Hospital, Paris, France

  • Centre Hospitalier Universitaire (CHU) de Poitiers, Poitiers, France

  • Centre Hospitalier Universitaire (CHU) de Toulouse, Toulouse, France

  • University Hospital Aachen, Aachen, Germany

  • Universitätsklinikum Freiburg, Freiburg im Breisgau, Germany

  • UKSH Campus Lubeck, Lübeck, Germany

  • Universitätsklinikum Mannheim, Mannheim, Germany

  • IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy

  • Azienda Ospedaliero Universitaria Careggi, Florence, Italy

  • AOU San Giovanni di Dio e Ruggi dAragonia, Salerno, Italy

  • Azienda Ospidaleira Universitaria Integrata Verona, Verona, Italy

  • University Medical Center Groningen, Groningen, Netherlands

  • Oslo University Hospital, Oslo, Norway

  • Public University Hospital No. 1 in Lublin, Lublin, Poland

  • Hospital Universitario Vall d'Hebron, Barcelona, Spain

  • Institut Català d'Oncologia - Hospital Duran i Reynals, Barcelona, Spain

  • Hospital Universitario Ramón y Cajal, Madrid, Spain

  • Universitätsspital Basel, Basel, Switzerland

  • Guy's Hospital - NHS Foundation Trust, London, London, United Kingdom

  • Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

  • University College London Hospital - NHS Foundation Trust, London, United Kingdom

Study leads
  • Rachael Easton, MD, Ph.D.

    Study Director

    Cogent Biosciences, Inc.